Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach

被引:0
作者
Dipta Dey
Partha Biswas
Priyanka Paul
Shafi Mahmud
Tanzila Ismail Ema
Arysha Alif Khan
Shahlaa Zernaz Ahmed
Mohammad Mehedi Hasan
Abu Saim Mohammad Saikat
Babry Fatema
Shabana Bibi
Md. Ataur Rahman
Bonglee Kim
机构
[1] Bangabandhu Sheikh Mujibur Rahman Science and Technology University,Department of Biochemistry and Molecular Biology, Life Science Faculty
[2] Jashore University of Science and Technology (JUST),Department of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology
[3] University of Rajshahi,Department of Genetic Engineering and Biotechnology
[4] North South University,Department of Biochemistry and Microbiology
[5] Mawlana Bhashani Science and Technology University,Department of Biochemistry and Molecular Biology, Faculty of Life Science
[6] Yunnan University,Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences
[7] International Islamic University,Department of Biological Sciences
[8] Islamic University,Global Biotechnology & Biomedical Research Network (GBBRN), Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences
[9] Kyung Hee University,Department of Pathology, College of Korean Medicine
[10] Kyung Hee University,Korean Medicine
来源
Molecular Diversity | 2023年 / 27卷
关键词
HCV infection; Liver cirrhosis; CD81 protein; ADMET; Docking protocol; MM-PBSA; Dynamic assessments;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1309 / 1322
页数:13
相关论文
共 503 条
[1]  
Fénéant L(2014)CD81 and hepatitis C virus (HCV) infection Viruses 6 535-572
[2]  
Levy S(2011)HCV routes of transmission: what goes around comes around Semin Liver Dis 31 340-346
[3]  
Cocquerel L(2002)Prevention of spread of hepatitis C Hepatology 36 S93-98
[4]  
Alter MJ(2008)Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission BMC Infect Dis 8 69-132
[5]  
Alter MJ(2017)Global epidemiology and burden of HCV infection and HCV-related disease Nat Rev Gastroenterol Hepatol 14 122-163
[6]  
Idrees M(2019)Bioavailability prediction of phytochemicals present in World Sci News 131 147-228
[7]  
Riazuddin S(2011) (Aiton) R. Br. by using Swiss-ADME tool Virol J 8 161-4296
[8]  
Thrift AP(2002)An overview of HCV molecular biology, replication and immune responses J Med Virol 68 221-10597
[9]  
El-Serag HB(1998)Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha J Virol 72 4288-892
[10]  
Kanwal F(2014)Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection J Virol 88 10584-514